According to the data of Cat's Eye Professional Edition, the movie "Lone Star Project" was released for 6 days, and the total box office broke 70 million.Xia Yiping's internal letter was alleged to have been copied from Weilai Li Bin. Xia Yiping, CEO of Jiyue, released an internal letter on the afternoon of 11th, acknowledging that the company was encountering difficulties and needed to adjust immediately. Some netizens pointed out that part of Xia Yiping's internal letter copied the internal letter of Weilai Li Bin in 2023. Xia Yiping's internal letter mentioned that the following four things must be done well in the new entrepreneurial period: 1. Adhere to the long-term investment in core technologies to maintain the leading edge; 2. Strengthen sales and service capacity building to cope with fierce market competition; 3. Merge departments and posts with duplicate functions and change inefficient internal workflow; 4. Reduce projects that cannot improve financial performance in the short term. In 2023, Li Bin's internal letter also mentioned: ensure long-term investment in core key technologies and maintain the leading edge of technology and products; Ensure that sales and service capabilities can cope with fierce market competition; Ensure that 9 core products of 3 brands are listed as scheduled; Organize efficiency improvement, merge redundant departments and posts, change inefficient internal workflow and division of labor, and cancel inefficient posts; Improve the efficiency of resources, postpone and reduce the project investment that can not improve the company's financial performance within 3 years. (Sina Technology)Extremely Yue insiders: Xia Yiping still stays in the company's on-site office and is seeking financing. I learned from the inside of Extremely Yue Automobile that on the morning of December 12, Extreme Yue CEO Xia Yiping appeared in the company's headquarters office. Xia Yiping said that he appeared first to prove to employees that he had not run away, to tide over the difficulties with the company, and second to communicate with employees face to face. "His main task at present is financing, and he is also actively contacting investors for help." Insiders revealed to reporters. (The Paper)
Yamato: Raising the target price of IWC to HK$ 20 has a more positive view on next year's revenue growth. Yamato published a report that under the strong demand from Malaysia, the bank has a more positive view on IWC's revenue growth next year. In addition, the bank believes that the external financing of operating GDSI, a data center outside the mainland, will release shareholder value. However, as GDSI will be separated from IWC's consolidated statements in the fourth quarter of this year, the bank believes that IWC's short-term re-evaluation will still mainly depend on its mainland business performance, so it still maintains a wait-and-see attitude. The bank maintained its "hold" rating on IWC, and its target price was raised from HK$ 8.6 to HK$ 20. Considering the increase in capital expenditure of IWC from 2025 to 2026, the bank raised its revenue forecast for this year and next by 5% to 24%, mainly due to the strong demand in the international market driven by short video platforms. In addition, in view of the fact that the company raised its capital expenditure guideline from 6.5 billion yuan to 11 billion yuan this year, the bank raised its capital expenditure forecast from 6.7 billion yuan to 11 billion yuan in 2024 and from 3.5 billion yuan to 10.5 billion yuan in 2025. In addition, the bank will raise the adjusted EBITDA forecast of IWC this year and next by 4% to 13% to consider the EBITDA contribution of its overseas business; It is estimated that the total revenue will increase by 15% this year (10% compared with the previous forecast) and 33% next year (15% compared with the previous forecast). The adjusted EBITDA is expected to increase by 11% and 25% this year and next (8% and 15% compared with the previous forecast).Renhe Pharmaceutical invested in Jiangxi to establish a health industry company. According to the enterprise search APP, Jiangxi Renhe Jiuniuai Health Industry Co., Ltd. was recently established, with Xin Li as the legal representative and a registered capital of 1 million yuan. Its business scope includes: food Internet sales, health food production, health care services (non-medical), health consulting services, sales of first-class medical devices, sales of agricultural and sideline products, etc. Enterprise survey shows that the company is jointly held by Renhe Pharmaceutical and Xin Li.Market News: NVIDIA has increased its recruitment in China, focusing on artificial intelligence to drive cars.
The main contract of CSI 500 stock index futures (IC) expanded to 1.00% in the day and is now reported at 6104.4 points. The main contract of CSI 500 stock index futures (IC) stood at 6100 points, rising by 0.99% in the day.China galaxy International lowered the target price of Yanghe shares from RMB 88.00 to RMB 84.00.South Korea's ruling party has made it a unified position within the party to oppose the "special inspection law for civil strife" and "Jin Jianchit's inspection law". South Korea's ruling National Power Party said that it will make it a unified position within the party to oppose the "special inspection law for civil strife" and "Jin Jianchit's inspection law". (CCTV News)
Strategy guide 12-13
Strategy guide
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
Strategy guide
12-13